Guoqian Sun

Title: Guoqian Sun: Innovator in Antibody Therapy

Introduction

Guoqian Sun is a distinguished inventor based in Beijing, China. With a focus on the development of innovative therapeutic solutions, he has made significant contributions to the field of biotechnology, particularly in antibody therapy.

Latest Patents

Guoqian Sun holds a patent for "Antibodies or antigen-binding fragments that bind to OX40". This patent describes antibodies that specifically target OX40, along with their antigen-binding fragments. These innovations are vital for the treatment of various diseases, including cancers. The patent includes detailed specifications of the heavy chain variable region with one or more CDRs featuring amino acid sequences set forth in the provided SEQ ID NOs: 1-12.

Career Highlights

Currently, Guoqian Sun works at Bioduro (Beijing) Co., Ltd., a leading company in the pharmaceutical and biotechnology sectors. His role involves research and development centered on advancing antibody-based therapies, contributing to the company’s initiatives in drug discovery and development.

Collaborations

Guoqian has collaborated with talented coworkers such as Jing Li and Chenguang Cai. Their joint efforts enhance the collaborative atmosphere at Bioduro, where innovation thrives through teamwork and shared expertise.

Conclusion

As an inventor, Guoqian Sun exemplifies the spirit of innovation in biotechnology. His work on antibodies targeting OX40 positions him at the forefront of research aimed at conquering challenging diseases like cancer. With ongoing collaborations and a commitment to advancing healthcare, Guoqian's contributions will undoubtedly leave a lasting impact in the field.